Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...

Biologists mapping the human microbiome expected to find new bacteria and viruses, not entities that slip through every ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

The collaboration with Sanofi focuses on developing bispecific antibodies for autoimmune diseases, leveraging predictive ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

But the bigger point is how foundational these stories are to how we narrate struggle and resilience. Middle school teaches ...

The analysis of dental remains from Dmanisi in the Republic of Georgia has important implications regarding the balance and ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

Biosplice Therapeutics, Inc. ("Biosplice"), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination (FDC) of BEM, a nucleotide analog ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...

A research team led by a researcher at the Medical University of South Carolina and partnering institutions has been awarded ...